Myrtelle to Present Clinical Data and Regulatory Progress for MYR-101 Gene Therapy Program at ASGCT 2026

B NEW YORK, May 11, 2026 /PRNewswire/ — Myrtelle, Inc., a clinical-stage gene therapy company selected by the FDA for the START Pilot Program and…
posteditor
posteditor
Articles: 21727

Other News